Evidence map›Paper›PMID 37160532›Full record

ArticleEndocrine pathology2023

Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.

Hemlata Jangir, Isheeta Ahuja, Shipra Agarwal, Vishesh Jain, Jagdish Prasad Meena, Sandeep Agarwala, Rajni Sharma, Mehar Chand Sharma, Venkateswaran K Iyer, Kalaivani Mani

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Diagnosis and grading of adrenal cortical carcinoma.Virchows Archiv : an international journal of pathology · 2026
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hemlata JangirDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.ORCID http://orcid.org/0000-0002-8357-8347
Isheeta AhujaDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.
Shipra AgarwalDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. drshipra0902@gmail.com.ORCID http://orcid.org/0000-0001-7037-4444
Vishesh JainDepartment of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India.ORCID http://orcid.org/0000-0002-9273-097X
Jagdish Prasad MeenaDepartment of Pediatric Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.ORCID http://orcid.org/0000-0001-6024-9762
Sandeep AgarwalaDepartment of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India.
Rajni SharmaDepartment of Pediatric Endocrinology, All India Institute of Medical Sciences, New Delhi, India.
Mehar Chand SharmaDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.ORCID http://orcid.org/0000-0002-7935-6047
Venkateswaran K IyerDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.ORCID http://orcid.org/0000-0003-1933-7562
Kalaivani ManiDepartment of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenocortical neoplasms are rare in childhood. Their histopathological categorization into benign and malignant is often challenging, impacting further management. While the AFIP/Wieneke scoring system is widely used for the prognostic classification of these tumors, it has limitations. Few other tumor scoring systems have evolved over the past few years. These have been validated in adults but not yet in pediatric patients. We evaluated a cohort of pediatric adrenocortical neoplasms to assess the applicability of AFIP/Wieneke criteria and the recently introduced Helsinki score and reticulin algorithm in predicting clinical outcomes. A tumor was considered 'clinically aggressive' in the presence of any of the following: metastases, recurrence, progressive disease, or death due to disease. Cases without any such event were considered 'clinically good'. Event-free survival time was the duration from the date of clinical presentation to any post-operative adverse event. For overall survival analysis, the endpoint was either the last follow-up or death due to disease.Using ROC curve analysis, the obtained cut-off Helsinki score of 24 could stratify the cases into two prognostically relevant groups. Survival analysis showed significant differences in the event-free and overall survival of these two groups of patients, validating the proposed cut-off. None of the three histopathological scoring systems could predict an unfavorable outcome with 100% accuracy. All showed a sensitivity of ≥ 80%, with the reticulin algorithm achieving 100% sensitivity. The specificity and accuracy of the AFIP/Wieneke criteria were the lowest (62.5% and 73.08%, respectively). While the Helsinki score (at the cut-off score of 24) and the reticulin algorithm had similar accuracy rates (80.77%, and 80%, respectively), the specificity of the former was higher (81.25%) than the latter (68.75%). A separate analysis revealed that the Ki-67 index at a cut-off of 18% had a sensitivity of 80% and a specificity of 81.25% for predicting an unfavorable outcome.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaAdultAlgorithmsChildHumansPrognosisReticulinReticulinAdrenocortical carcinomaAdrenocortical neoplasmAFIP/Wieneke criteriaHelsinki scoreKi-67Linn-Weiss-Bisceglia criteriaPD-L1PediatricReticulin Algorithm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.